This observed increase may reflect the high prevalence of metabolic comorbidities among patients with PCOS, rather than expanded prescribing of GLP-1s specifically for PCOS
Serious risks can include pancreatitis, gallbladder disease, and kidney injury
This article explains what triple agonist peptides are, how they differ from the single and dual agonist compounds that preceded them, what the term "GLP-3" refers to (and what it doesn't), and what Canadian researchers entering this category should understand before evaluating specific compounds
Excessive doses may increase your risk of kidney damage
J Biol Chem 284:1072810736 Chepurny OG, Kelley GG, Dzhura I, Leech CA, Roe MW, Dzhura E, Li X, Schwede F, Genieser HG, Holz GG (2010) PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2-O-Me-cAMP-AM in human islets of Langerhans
It is said to help boost skin health and appearance and reduce wrinkles